US Stock MarketDetailed Quotes
ANAB AnaptysBio
- 21.000
- +2.130+11.29%
Close Apr 26 16:00 ET
- 20.500
- -0.500-2.38%
Post 18:01 ET
573.69MMarket Cap-3453P/E (TTM)
21.610High18.715Low649.41KVolume18.920Open18.870Pre Close13.36MTurnover4.25%Turnover RatioLossP/E (Static)27.32MShares27.50052wk High6.51P/B321.07MFloat Cap13.36052wk Low--Dividend TTM15.29MShs Float134.000Historical High--Div YieldTTM15.34%Amplitude10.000Historical Low20.577Avg Price1Lot Size
About AnaptysBio Company
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
Company Profile
SymbolANAB
Company NameAnaptysBio
Listing DateJan 26, 2017
Issue Price15.00
Founded2005
CEOMr. Daniel R. Faga
MarketNASDAQ
Employees117
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10770 Wateridge Circle,Suite 210
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121-5801
Phone1-858-362-6295
Websitehttp://www.anaptysbio.com
Company Executives
- Name
- Position
- Salary
- Daniel R. Faga
- Director, President and Chief Executive Officer
- 7.46M
- Paul F. Lizzul, M.D.
- Chief Medical Officer
- 2.44M
- Eric J. Loumeau
- Chief Legal Officer
- 2.26M
- Dennis M. Mulroy
- Chief Financial Officer and Principal Accounting Officer
- --
- John A. Orwin
- Chairman of the Board
- 338.08K
- Dr. Magda Marquet, PhD
- Independent Director
- 318.38K
- Dr. J. Anthony Ware
- Independent Director
- 338.38K
- Hollings C. Renton
- Independent Director
- 342.38K
- Dr. Rita I. Jain, M.D.
- Independent Director
- 495.60K
- Dr. Dennis M. Fenton,PhD
- Independent Director
- 331.88K
- Oleg Nodelman
- Independent Director
- --
- John P. Schmid
- Independent Director
- 335.38K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
